Literature DB >> 23352342

Vernal keratoconjunctivitis-like disease in adults.

Andrea Leonardi1, Daniela Lazzarini, Laura Motterle, Massimo Bortolotti, Velika Deligianni, S John Curnow, Stefano Bonini, Iva A Fregona.   

Abstract

PURPOSE: To identify clinical, demographic, immunologic, and health-related quality-of-life data from a cohort of vernal keratoconjunctivitis (VKC) patients with the onset of the disease after puberty (VKC-like disease).
DESIGN: Retrospective, observational case series.
METHODS: Forty-nine patients with late-onset VKC-like disease from among 600 consecutive VKC patients. History of disease, test results for allergen sensitivity, signs and symptoms, impact of disease on work productivity, health-related quality of life, and treatment satisfaction were assessed. In addition, multiplex bead analysis for Th1/Th2 cytokines were carried out in tear samples from 20 VKC patients (10 adults and 10 children) and from 10 normal subjects.
RESULTS: A family history of allergy was positive in only 28% and positive prick test results were present in 55% of the 49 VKC-like adult patients. Based on typical signs and symptoms, 48% were affected by the limbal form, 33% were affected by the tarsal form, and 19% were affected by the mixed form. Corneal ulcer complicated the disease in only 2 adult patients. Although the disease was not considered a limiting factor for work, productivity was reduced by 26% and social activities were reduced by 31% during active flare-ups. No significant differences were found in tear cytokine pattern production between VKC in children and VKC in adults.
CONCLUSIONS: A late onset VKC-like disease can appear in young adults with signs and symptoms similar to those in pediatric disease, but with less corneal involvement.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23352342     DOI: 10.1016/j.ajo.2012.11.018

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  [Vernal keratoconjunctivitis].

Authors:  U Pleyer; A Leonardi
Journal:  Ophthalmologe       Date:  2015-02       Impact factor: 1.059

2.  Allergic eye disease: Blocking LTB4/C5 in vivo suppressed disease and Th2 & Th9 cells.

Authors:  Malihe Eskandarpour; Xiaozhe Zhang; Alessandra Micera; Sarah Zaher; Frank D P Larkin; Miles Nunn; Stefano Bonini; Wynne Weston-Davies; Virginia L Calder
Journal:  Allergy       Date:  2021-10-15       Impact factor: 14.710

3.  Management of vernal keratoconjunctivitis.

Authors:  Andrea Leonardi
Journal:  Ophthalmol Ther       Date:  2013-09-07

4.  Quiescent and Active Tear Protein Profiles to Predict Vernal Keratoconjunctivitis Reactivation.

Authors:  Alessandra Micera; Antonio Di Zazzo; Graziana Esposito; Roberto Sgrulletta; Virginia L Calder; Stefano Bonini
Journal:  Biomed Res Int       Date:  2016-02-17       Impact factor: 3.411

5.  The role of human immunodeficiency virus in the pathogenesis of vernal keratoconjunctivitis-like disease in adults: A demographic and epidemiological study.

Authors:  Anine Kritzinger; Anthony G Zaborowski; Wilbert Sibanda; Linda Visser
Journal:  Indian J Ophthalmol       Date:  2020-08       Impact factor: 1.848

6.  The effect of COVID-19 imposed lockdown on Italian children with Vernal Keratoconjunctivitis.

Authors:  Artesani Maria Cristina; Esposito Mariacristina; Sacchetti Marta; Mennini Maurizio; Romanzo Antonino; Buzzonetti Luca; Fiocchi Alessandro Giovanni; Sansone Andrea
Journal:  World Allergy Organ J       Date:  2022-09-12       Impact factor: 5.516

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.